Castle Biosciences Inc (CSTL) support and resistance · rev $187.2M
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
This page maps Castle Biosciences Inc (CSTL) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
CSTL currently screens at market cap $570.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CSTL 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CSTL quote page for the session range and the stock page for the full model.
Not investment advice.